shortagewatch

Home / Cancer and immune system / Ifosfamide

ATC L01AA06 · Antineoplastic Agents

Ifosfamide shortage

As of 31 Oct 2026, Ifosfamide has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Austria, Belgium), covering 14 products.

Countries4/5
Products14packs or presentations
Short since16 Dec 202510 months ago
Earliest return31 Dec 2026company estimate
No return date0products
Main reasonManufacturing problem
Germany10 packs shortItaly1 pack shortSpainNo reported shortageAustria2 packs shortBelgium1 pack short

Timeline

GermanyItalyAustriaBelgium
202620272028HoloxanHoloxanHoloxanHoloxanHoloxanHoloxanHoloxanHoloxanHoloxanHoloxanHoloxanHoloxanIFO-cell 2g Konzentrat zur Herstellung einerIFO-cell 2g Konzentrat zur Herstellung einer InfusionslösungIFO-cell 5 g Konzentrat zur Herstellung eineIFO-cell 5 g Konzentrat zur Herstellung einer InfusionslösungIFO-cell N 1000IFO-cell N 1000IFO-cell N 2000IFO-cell N 2000HOLOXANHOLOXANHoloxan 1 g - Trockensubstanz zur InjektionsHoloxan 1 g - Trockensubstanz zur Injektionsbereitung, 1 StückHoloxan 2 g - Trockensubstanz zur InjektionsHoloxan 2 g - Trockensubstanz zur Injektionsbereitung, 1 StückHoloxan 1 g inj. sol. (pwdr.) i.v. vial 10 xHoloxan 1 g inj. sol. (pwdr.) i.v. vial 10 x 1000 mgtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEHoloxanBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEHoloxanBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEHoloxanBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEHoloxanBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEHoloxanBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEHoloxanBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEIFO-cell 2g Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH3 Aug 202631 Dec 2027Manufacturing problem
Probleme in der Herstellung
DEIFO-cell 5 g Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH17 Aug 202631 Dec 2027Manufacturing problem
Probleme in der Herstellung
DEIFO-cell N 1000STADAPHARM GmbH17 Aug 202631 Dec 2027Manufacturing problem
Probleme in der Herstellung
DEIFO-cell N 2000STADAPHARM GmbH17 Aug 202631 Dec 2027Manufacturing problem
Probleme in der Herstellung
ITHOLOXANBAXTER S.P.A.16 Dec 202531 Mar 2027Increased demand
Elevata richiesta/problemi produttivi: distribuzione contingentata
ATHoloxan 1 g - Trockensubstanz zur Injektionsbereitung, 1 Stück limitedBaxter Healthcare GmbH26 Jan 202631 Mar 2027Manufacturing problem
Kapazitätsengpässe bei der Herstellung
ATHoloxan 2 g - Trockensubstanz zur Injektionsbereitung, 1 Stück limitedBaxter Healthcare GmbH26 Jan 202631 Mar 2027Manufacturing problem
Kapazitätsengpässe bei der Herstellung
BEHoloxan 1 g inj. sol. (pwdr.) i.v. vial 10 x 1000 mg limitedBaxter28 Jan 202631 Dec 2026Manufacturing problem
Delay in the release of the end product

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Bendamustine Cyclophosphamide Melphalan Trofosfamide